Clinical Trial Update: A Trial of a Botanical Drug (EISO) for Treatment of Mild-to-Moderate Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 trial of a botanical drug (EISO) for mild-to-moderate plaque psoriasis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• EISO

Snippet

Sponsor: Santalis Pharmaceuticals, Inc. | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2019-05-29